The T1 CRC Working Group aims to perform multicenter multidisciplinairy research. Here, we summarize our current research projects.
The aim of the COMET T1 CRC project is to develop a computer-aided diagnosis system based on artificial intelligence to improve the endoscopic recognition of early colorectal carcinoma.
In this project, we collect endoscopic images and videos of colorectal lesions in all available image enhancement techniques with the gold standard histopathology. We use this data to train and test the computer-aided diagnosis system.
Inclusion criteria
Patient ≥ 18 years old with an untreated colorectal lesion
– ≥10 mm with or without a suspicion of colorectal carcinoma
– <10 mm with a suspicion of colorectal carcinoma
Exclusion criteria
– Familial adenomatous polyposis
– Active inflammation around the colorectal lesion
Principal investigator: Erik Schoon
Coordinating researcher: Ayla Thijssen
Contact: a.thijssen@maastrichtuniversity.nl, +3143 388 1844
Recruitment
Data analysis
Complete
J. Hanevelt MD- PhD candidate
Gastroenterology and hepatology department, Isala
E-mail: j.hanevelt@isala.nl / limeric@isala.nl
Tel: +31 88 624 4340 / 06 37421727
Dr. H.L. van Westreenen
Department of Surgery Isala
E-mail: h.l.van.westreenen@isala.nl
Tel: +31 38 424 6299
Recruitment
Data analysis
Complete
“Long-term oncological outcomes of eFTR after previous incomplete resection of low-risk T1 CRC”
The aim of this nationwide, multicentre, prospective cohort study is to evaluate the feasibility and oncological safety of eFTR scar excision after incomplete resection of low-risk T1 CRC. We aim to include a total of 153 patients with histologically confirmed T1 CRC less than 3 cm in diameter. Patients with additional histological risk factors other than Rx/R1 resection margins will be excluded. A second review by one of our study pathologists will be performed to confirm the absence of other histological risk factors. After eFTR scar excision, patients will be followed according to the current protocol for high-risk T1 CRC as outlined in the Dutch CRC guideline. The primary endpoint is the 2-year and 5-year luminal local recurrence rate. Secondary endpoints include the proportion of curative eFTR resections, the feasibility of complete scar excision on histology, 2-year and 5-year nodal and/or distant recurrence rates, 5-year disease-specific and overall survival, and procedure-related adverse events and safety of eFTR compared to surgery.
Principal investigator: Barbara A.J. Bastiaansen
Project leader: Sander C. Albers,
s.c.albers@amsterdamumc.nl
Recruitment
Data analysis
Complete
The PATCH study aims to validate a previously developed risk model for pedunculated T1 CRC and to train pathologists in the assessment of histopathologic features involved in the model. Principal investigators: M.M. Lacle, L.M.G. Moons, S.G. Elias. Project leader: L. van der Schee
Recruitment
Data analysis
Complete
Recruitment
Data analysis
Complete
The contamination study aims to study whether tumor seeding by contamination of colonoscopy instruments could be a cause of mCRC Principal investigator: T. Seerden
Recruitment
Data analysis
Complete
This study aims to assess the short term outcomes (morbidity and mortality) after surgical treatment for T1 CRC, and to compare this with surgical resection of advanced CRC Principal investigator: K.C.M.J. Peeters Project leader: N.C.A. Vermeer
Recruitment
Data analysis
Complete
This pilot aims to test whether liquid biopsies could be of value for risk stratification of T1 colorectal cancer Principal investigator: M.M. Lacle, L.M.G. Moons Project leader: C. Spoto, Y. Backes
Recruitment
Data analysis
Complete